We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Trending News

T cells.

Immune Cells “Remember” the Pain of Newborn Injuries

A scientist in a lab holding up a centrifuge tube.

Materials Follow the “Rule of Four” — But Scientists Don’t Know Why Yet

A white blood cell.

Promising Treatment Approach for Aggressive Leukemia Identified

Siblings' Rare Genetic Mutation Offers Clues for Type 1 Diabetes Therapy

Neuro-Cognitive Computer Models Make Reading More Efficient

Mobilizing Microglia in the Fight Against Alzheimer’s Disease

News

Biocartis And Microbiome Collaborate

Collaboration aims to develop rapid and sensitive sepsis test.

arGEN-X Opens Expansion Cohort in Phase 1b Study of ARGX-111

Objective is to further characterize the safety of ARGX-111 in patients with MET amplified cancers.

Protea Announces Agreement to Acquire vivoPharm

Combined Company to develop and market new services for pharmaceutical R&D.

Bristol-Myers Squibb and uniQure Enter into Strategic Collaboration

Collaboration to develop gene therapies for cardiovascular diseases.

OncoMed and Lilly Enter Clinical Supply Agreement

Agreement to evaluate the combination of Demcizumab and Alimta® (pemetrexed for injection) in lung cancer.

AMRI to Close Holywell, U.K. API Manufacturing Facility

Company plans to cease operations at the site by the end of 2015.

Merck and Pfizer Finalize Agreement to Co-Promote XALKORI®

Co-promotion of XALKORI allows the alliance between Merck KGaA, Darmstadt, Germany, and Pfizer to establish a combined oncology sales organization in key markets for the program.

Cells Exercise Suboptimal Strategy to Survive

Rice University study shows it’s not always good for cells’ metabolism to work at peak efficiency.

Analytical Innovations Bring $10 Million Back to National Laboratory, Battelle

Advances enhance performance of mass spectrometers.

GSK to Establish Global Vaccines R&D Centre in the US

New hub based in Rockville, MD expands GSK’s global vaccines R&D footprint.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter